2BBBullish & Bearish
Zentalis Pharmaceuticals, Inc. (ZNTL) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 48 out of 100.
Zentalis Pharmaceuticals, Inc.’s current 2BB score is 48 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 58 | Moderate |
| Momentum | 58 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 93 | Very Strong |
| Risk | 69 | High |
| Founded | 2014 |
| Employees | 106 |
| 52-week range | $1.21 – $6.95 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-24 | — | -0.5485 | — | $0.00 |
| 2026-11-09 | — | -0.5771 | — | $0.00 |
| 2026-08-04 | — | -0.4997 | — | $0.00 |
| 2026-05-12 | -0.5 | -0.4861 | $0.00 | $0.00 |